1. Date of change: 115/05/22 2. Type of personnel change (legal entity director, legal entity supervisor, independent director, individual director, or individual supervisor): Director and Independent Director 3. Title and name of the predecessor: (1) Director: Xu Luhui (2) Director: Ling Yufang (3) Director: Qiu Quancheng (4) Director: Zhang Gaorong (5) Independent Director: Guo Boren (6) Independent Director: Lin Qingbo (7) Independent Director: Peng Xianli 4. Resume of the predecessor: (1) Director Xu Luhui: Chairman and Chief Strategy Officer of KangPai Biotech Co., Ltd. (2) Director Ling Yufang: CEO and R&D Chief of KangPai Biotech Co., Ltd. (3) Director Qiu Quancheng: Director of Yidingxing Technology Co., Ltd. (4) Director Zhang Gaorong: Director of Chisejia Clinic (5) Independent Director Guo Boren: Financial Manager of Zhongwan Co., Ltd. (6) Independent Director Lin Qingbo: Distinguished Professor, Institute of Neuroscience, National Yang Ming Chiao Tung University (7) Independent Director Peng Xianli: Director of Peng Xianli Dermatology Clinic 5. Title and name of the successor: (1) Director: Xu Luhui (2) Director: Ling Yufang (3) Director: Qiu Quancheng (4) Director: Zhang Gaorong (5) Independent Director: Lin Qingbo (6) Independent Director: Luo Baozhu (7) Independent Director: Peng Xianli 6. Resume of the successor: (1) Director Xu Luhui: Chairman and Chief Strategy Officer of KangPai Biotech Co., Ltd. (2) Director Ling Yufang: CEO and R&D Chief of KangPai Biotech Co., Ltd. (3) Director Qiu Quancheng: Director of Yidingxing Technology Co., Ltd. (4) Director Zhang Gaorong: Director of Chisejia Clinic (5) Independent Director Lin Qingbo: Distinguished Professor, Institute of Neuroscience, National Yang Ming Chiao Tung University (6) Independent Director Luo Baozhu: Independent Director of Everbest Biotech Co., Ltd.; Independent Director of PharmaEngine, Inc. (7) Independent Director Peng Xianli: Director of Peng Xianli Dermatology Clinic 7. Type of change: Expiration of term 8. Reason for change: Comprehensive re-election due to expiration of term 9. Shareholding at the time of appointment: (1) Director: Xu Luhui 107,541,980 shares (2) Director: Ling Yufang 152,297,260 shares (3) Director: Qiu Quancheng 17,199,060 shares (4) Director: Zhang Gaorong 17,600,080 shares (5) Independent Director: Lin Qingbo 29,000 shares (6) Independent Director: Luo Baozhu 0 shares (7) Independent Director: Peng Xianli 0 shares 10. Original term: 112/06/29 ~ 115/06/28 11. Effective date of new appointment: 115/05/22 12. Percentage of director changes during the same term: Not applicable (comprehensive re-election). 13. Percentage of independent director changes during the same term: Not applicable (comprehensive re-election). 14. Percentage of supervisor changes during the same term: Not applicable. 15. Whether one-third or more of the directors have changed: No. 16. Other information: None.

FACT BOX

  • Source: PR Times
  • Category: 人事
  • Dates in source: 115/05/22